Search

everythinglearnresearchcommunity

for

Search:↓

Many people with hair loss experience scalp pain known as trichodynia, but the causes are unclear and treatments vary.

The model and estimator can predict drug exposure in kidney transplant patients well.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Eating a balanced diet with specific nutrients can help manage menopause symptoms and prevent related health issues.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Oral alitretinoin can quickly regrow hair in alopecia universalis.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Use NSAIDs for immediate migraine relief and β-blockers for prevention; tailor treatment to the individual.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

People with migraines often have mental health conditions, and treatment should be personalized to address both issues safely.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

The conclusion is that careful management of both psychiatric and skin conditions is crucial for HIV patients, using medication and interdisciplinary approaches.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

Methylphenidate can cause hair loss, which stops when the drug is discontinued.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Sodium valproate can cause reversible hair loss in some patients.

Sertraline, an antidepressant, may rarely cause hair loss.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

Hair loss can significantly impact a person's mental health, causing issues like anxiety and depression, and stress can trigger hair loss.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.